Toxoplasma gondii is a protozoan parasite that is capable of forming tissue cysts throughout the human body, including skeletal muscle, myocardium, the brain, and eyes. Clinical manifestations generally are not observed in immunocompetent individuals, however, it may vary from a mild febrile illness and lymphadenopathy, to more severe complications in immunocompromised individuals including retinochoroiditis and vision loss. Primary acquired infection during pregnancy may result in congenital infection which can lead to miscarriages, stillbirths, hydrocephalus; symptoms may develop later in the childs life including intracranial calcifications, mental disability, and vision loss. Current methods used to test for T. gondii infection include automated or manual EIA for IgG and IgM antibodies, and automated IgG Avidity testing. Due to the sequelae that follow on from Toxoplasma gondii infection, screening is of high importance especially during gestation, where these can be avoided if treatment is administered promptly.